ANDA 74918, held by Barr. Naltrexone Hydrochloride.
As of Nov 16, 2026, ANDA 74918 (Naltrexone Hydrochloride), held by Barr, was first approved by FDA on May 8, 1998, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 8, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Naltrexone Hydrochloride50MG · tablet;oral | Naltrexone Hydrochloride | Rx |
| Sep 2, 2015 | Supplement 18Labeling · Standard review | Approved | None posted |
| Sep 2, 2015 | Supplement 17Labeling · Standard review | Approved | None posted |
| Nov 20, 2002 | Supplement 12Labeling | Approved | None posted |
| Apr 19, 2002 | Supplement 9Manufacturing | Approved | None posted |
| Jan 29, 2001 | Supplement 8Labeling | Approved | None posted |
| Sep 14, 2000 | Supplement 7Labeling | Approved | None posted |
| Dec 21, 1999 | Supplement 6Manufacturing | Approved | None posted |
| Nov 22, 1999 | Supplement 5Manufacturing | Approved | None posted |
| Nov 22, 1999 | Supplement 4Manufacturing | Approved | None posted |
| May 20, 1999 | Supplement 3Manufacturing | Approved | None posted |
| Mar 22, 1999 | Supplement 2Manufacturing | Approved | None posted |
| Dec 1, 1998 | Supplement 1Manufacturing | Approved | None posted |
| May 8, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters